Resonac Holdings Corporation Unsponsored ADR (OTCMKTS:SHWDY – Get Free Report) saw a large drop in short interest in October. As of October 15th, there was short interest totaling 42 shares, a drop of 45.5% from the September 30th total of 77 shares. Based on an average trading volume of 110 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.0% of the shares of the stock are short sold.
Resonac Trading Down 0.7%
Shares of OTCMKTS:SHWDY traded down $0.61 during midday trading on Monday, hitting $86.39. 183 shares of the stock were exchanged, compared to its average volume of 479. The business’s 50-day moving average price is $99.31 and its 200 day moving average price is $88.97. Resonac has a 12 month low of $35.15 and a 12 month high of $126.17. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.14 and a current ratio of 1.54. The stock has a market capitalization of $16.51 billion, a price-to-earnings ratio of 47.05 and a beta of 0.76.
Resonac (OTCMKTS:SHWDY – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $1.03 EPS for the quarter. Resonac had a net margin of 4.05% and a return on equity of 7.54%. The business had revenue of $2.32 billion for the quarter.
About Resonac
Resonac Holdings Corporation is a Japan-based chemical and materials company formerly known as Showa Denko. The company was rebranded as Resonac in 2023 following the integration of Showa Denko and Showa Denko Materials, which was previously known as Hitachi Chemical.
Resonac develops and manufactures advanced materials and chemical products used in semiconductor and electronic applications, mobility, energy, and industrial markets. Its offerings include semiconductor packaging materials, silicon carbide and other semiconductor-related materials, graphite electrodes, battery materials, specialty chemicals, petrochemical products, and high-performance resins and films.
The company serves customers in Japan and international markets through a global manufacturing, research, and sales network.
See Also
- Five stocks we like better than Resonac
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Resonac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resonac and related companies with MarketBeat.com's FREE daily email newsletter.
